Form 4 Tracker
Kymera Therapeutics, Inc.
KYMR

24 insider filings · Latest: May 11, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 11, 2026May 11 8:58 PMElena RidloffDirector
Sale
3,000$87.00$261.0K0(D)

View →

May 11, 2026May 11 8:35 PMELENA RIDLOFF
Proposed Sale
3,000$86.08$258.2K

View →

Apr 29, 2026Apr 29 9:00 PMNello MainolfiDirector, Chief Executive Officer
Sale
30,000$81.18$2.4M666,195(D)

View →

Apr 29, 2026Apr 29 8:07 PMMainolfi Nello
Proposed Sale
30,000$82.47$2.5M

View →

Apr 22, 2026Apr 24 8:33 PMBruce BoothDirector
Sale
6,000$89.96$539.8K674,944(I)

View →

Apr 22, 2026Apr 24 8:30 PMJeremy G ChadwickChief Operating Officer
Sale
300$90.00$27.0K61,202(D)

View →

Apr 22, 2026Apr 22 8:52 PMAtlas Venture Fund X, LP
Proposed Sale
88$88.07$7.8K

View →

Apr 22, 2026Apr 22 8:52 PMAtlas Venture Opportunity Fund I, LP
Proposed Sale
12$88.07$1.1K

View →

Apr 22, 2026Apr 22 8:30 PMJEREMY CHADWICK
Proposed Sale
300$88.07$26.4K

View →

Apr 14, 2026Apr 16 10:30 PMNoah GoodmanChief Business Officer
Sale
1,347$90.00$121.2K50,195.438(D)

View →

Apr 15, 2026Apr 16 10:30 PMJeremy G ChadwickChief Operating Officer
Sale
1,300$90.00$117.0K61,202(D)

View →

Apr 14, 2026Apr 16 10:30 PMJeremy G ChadwickChief Operating Officer
Sale
5,251$90.00$472.6K61,202(D)

View →

Apr 15, 2026Apr 16 10:16 PMBruce BoothDirector
Sale
5,335$90.04$480.4K674,956(I)

View →

Apr 14, 2026Apr 16 10:16 PMBruce BoothDirector
Sale
4,159$89.97$374.2K0(D)

View →

Apr 15, 2026Apr 15 8:51 PMAtlas Venture Opportunity Fund I, LP
Proposed Sale
385$89.87$34.6K

View →

Apr 15, 2026Apr 15 8:51 PMAtlas Venture Fund X, LP
Proposed Sale
2,750$89.87$247.1K

View →

Apr 15, 2026Apr 15 8:41 PMJEREMY CHADWICK
Proposed Sale
1,300$89.87$116.8K

View →

Apr 14, 2026Apr 14 9:19 PMBruce Booth
Proposed Sale
24,000$88.53$2.1M

View →

Apr 14, 2026Apr 14 8:37 PMJEREMY CHADWICK
Proposed Sale
5,251$88.53$464.9K

View →

Apr 10, 2026Apr 10 8:45 PMNoah GoodmanChief Business Officer
Sale
2,000$87.35$174.7K51,542.438(D)

View →

Page 1 of 5

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 2, 2026Mar 4 11:00 PMJared GollobChief Medical Officer
Grant/Award
35,300$90.1035,300(D)

View →

Mar 2, 2026Mar 4 11:00 PMBruce N. JacobsChief Financial Officer
Grant/Award
35,300$90.1035,300(D)

View →

Mar 2, 2026Mar 4 11:00 PMNello MainolfiDirector, Chief Executive Officer
Grant/Award
215,000$90.10215,000(D)

View →

Feb 25, 2026Feb 25 10:24 PMNello MainolfiDirector, Chief Executive Officer
Option Exercise
30,000$2.08245,559(D)

View →

Feb 20, 2026Feb 20 10:30 PMPamela EspositoDirector
Option Exercise
2,500$49.102,500(D)

View →

Jan 20, 2026Jan 20 11:30 PMPamela EspositoDirector
Option Exercise
5,500$49.105,000(D)

View →

Dec 31, 2025Dec 31 10:23 PMNello MainolfiDirector, Chief Executive Officer
Option Exercise
30,000$2.08275,559(D)

View →

← Previous

Page 2 of 2